6. References
- Clinical Pharmacology [database online]. Tampa, FL: Elsevier; 2022. Available at: http://clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed September 6, 2022.
- IMB Micromedex® DRUGDEX® (electronic version). Truven Health Analytics, Greenwood Village, Colorado, USA. Available at: http://www.micromedexsolutions.com.libproxy.uthscsa.edu. Accessed September 6, 2022.
- Acarbose tablets (Acarbose®) package insert. Heritage Pharmaceuticals, Inc., March 2022.
- Miglitol tablets (Glyset®) package insert. Sun Pharmaceuticals, Inc., January 2020.
- Metformin Hydrochloride tablets package insert. Ascend Laboratories, February 2017.
- Metformin extended-release tablets (Fortamet®) package insert. Shionogi, Inc., March 2021.
- Metformin extended-release tablets (Glumetza®) package insert. Santarus, Inc., August 2019.
- Metformin oral solution (Riomet®) package insert. Sun Pharmaceutical Industries Inc., December 2018.
- Colesevelam tablets and packets for oral suspension (Welchol®) package insert. Cosette, October 2021.
- Alogliptin tablets (Nesina®) package insert. Takeda Pharmaceuticals America, Inc., March 2022.
- Linagliptin tablets (Tradjenta®) package insert. Boehringer Ingelheim Pharmaceuticals, Inc., April 2022.
- Saxagliptin tablets (Onglyza®) package insert. AstraZeneca AB, July 2021.
- Sitagliptin tablets (Januvia®) package insert. Merck & Co., Inc., July 2022.
- Bromocriptine tablets (Cycloset®) package insert. Santarus, Inc., November 2020.
- Semaglutide (Rybelsus®) tablets package insert. Novo Nordisk, June 2022.
- Husain M, Birkenfeld AL, Donsmark M, et al. Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes. New England Journal of Medicine. 2019;381(9):841-851.
- Nateglinide tablets package insert. Modavar Pharmaceuticals, LLC., March 2022.
- Repaglinide tablets package insert. Aurobindo Pharma Limited, February 2022.
- Canagliflozin tablets (Invokana®) package insert. Janssen Pharmaceuticals, Inc., November 2021.
- Dapagliflozin tablets (Farxiga®) package insert. AstraZeneca, July 2022.
- Empagliflozin tablets (Jardiance®) package insert. Boehringer Ingelheim Pharmaceuticals, Inc., March 2022.
- Ertugliflozin tablets (Steglatro®) package insert. Merck Sharp & Dohme, LLC., May 2022.
- Glimepiride tablets (Amaryl®) package insert. Sanofi Aventis US, LLC, January 2021.
- Glipizide tablets package insert. Actavis Pharma, Inc., April 2022.
- Glipizide XL extended-release tablets (Glucotrol® XL) package insert. Roerig, November 2021.
- Glyburide tablets package insert. Amneal Pharmaceuticals of New York, LLC., December 2019.
- Glyburide tablets (Glynase®) package insert. Pharmacia and Upjohn Company, LLC., October 2017.
- Pioglitazone tablets (Actos®) package insert. Takeda Pharmaceuticals North America, Inc., December 2021.
- Rosiglitazone tablets (Avandia®) package insert. GlaxoSmithKline, February 2019.
- Alogliptin/metformin hydrochloride tablets (Kazano®) package insert. Takeda Pharmaceuticals America, Inc., March 2022.
- Alogliptin/pioglitazone hydrochloride tablets (Oseni®) package insert. Takeda Pharmaceuticals America, Inc., March 2022.
- Canagliflozin/metformin tablets (Invokamet®) and canagliflozin/metformin extended-release tablets (Invokamet® XR) package insert. Janssen Pharmaceuticals, Inc., November 2021.
- Dapagliflozin/metformin hydrochloride extended-release tablets (Xigduo® XR) package insert. AstraZeneca Pharmaceuticals LP., April 2022.
- Dapagliflozin/saxagliptin tablets (Qtern®) package insert. AstraZeneca Pharmaceuticals LP., March 2022.
- Empagliflozin/linagliptin tablets (Glyxambi®) package insert. Boehringer Ingelheim Pharmaceuticals, Inc., March 2022.
- Empagliflozin/metformin hydrochloride tablets (Synjardy®) package insert. Boehringer Ingelheim Pharmaceuticals, Inc., March 2022.
- Empagliflozin/metformin hydrochloride extended-release tablets (Synjardy® XR) package insert. Boehringer Ingelheim Pharmaceuticals, Inc., March 2022.
- Empagliflozin/linagliptin/metformin hydrochloride extended-release tablets (Trijardy® XR) package insert. Boehringer Ingelheim Pharmaceuticals, Inc., June 2021.
- Ertugliflozin/metformin hydrochloride tablets (Segluromet®) package insert. Merck & Co., Inc., May 2022.
- Ertugliflozin/sitagliptin phosphate tablets (Steglujan®) package insert. Merck Sharp & Dohme, LLC., June 2022.
- Glipizide/metformin hydrochloride tablets package insert. Heritage Pharmaceuticals Inc., December 2020.
- Glyburide/metformin hydrochloride tablets package insert. Actavis Pharma, Inc., May 2020.
- Linagliptin/metformin hydrochloride tablets (Jentadueto®) package insert. Boehringer Ingelheim Pharmaceuticals, Inc., April 2022.
- Linagliptin/metformin hydrochloride extended-release tablets (Jentadueto® XR) package insert. Boehringer Ingelheim Pharmaceuticals, Inc., October 2021.
- Glimepiride/pioglitazone tablets (Duetact®) package insert. Takeda Pharmaceuticals America, Inc., December 2021.
- Metformin hydrochloride/pioglitazone hydrochloride tablets (Actoplus Met®) package insert. Takeda Pharmaceuticals America, Inc., December 2021.
- Saxagliptin/metformin hydrochloride extended-release tablet (Kombiglyze® XR) package insert. AstraZeneca Pharmaceuticals LP., October 2019.
- Sitagliptin/metformin hydrochloride (Janumet®) package insert. Merck & Co., Inc., July 2022.
- Sitagliptin/metformin extended-release tablets (Janumet® XR) package insert. Merck & Co., Inc., July 2022.
- American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes -2022. Diabetes Care. 2022;45(Suppl. 1):S125–S143.